US 11236175
T cell modifying compounds and uses thereof
granted A61KA61K35/26A61K40/11
Quick answer
US patent 11236175 (T cell modifying compounds and uses thereof) held by Sangamo Therapeutics, Inc. expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K35/26, A61K40/11, A61K40/31, A61K40/4205